Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is This Dividend Growth Stock a Buy?

TheMotleyFool

0 0

Economic concerns ranging from elevated inflation to interest rate hikes have heavily weighed on financial markets this year. This explains why the S&P 500 index has dropped over 17% so far in 2022.

But many stocks have outperformed the index during this time, especially in healthcare. Down just 11% to this point in the year, Stryker (NYSE: SYK) fits into this category. This raises the following two questions: Can the stock's market-beating performance continue? And is Stryker a buy?

Let's dive into the company's fundamentals and valuation to get answers to these questions.

Source Fool.com

Like: 0

SYK

Teilen